generic semaglutide Canada approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Canada's Regulatory Changes May Open

In some areas, its clear that GLP-1s have clearly strong, positive effects on an individuals health and well-being (i.e., diabetes, obesity), and in other areas, its not yet clear, but we may soon find the same (i.e., neurological diseases)

Consultation with a registered dietitian can help develop an appropriate nutrition plan

The oral form of semaglutide, Rybelsus , further expands its reach, offering a non-injectable option, which appeals to a larger subset of patients who are hesitant about injections

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, openlabel, phase 3b trial